Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease - PubMed
Review
Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease
R E Besser et al. Annu Rev Med. 1999.
Abstract
Escherichia coli O157:H7 is an increasingly common cause of a variety of illnesses, including bloody diarrhea and the hemolytic uremic syndrome. This emerging infectious agent was first identified in 1982 and has been isolated with increasing frequency since then. This chapter reviews the epidemiology, clinical spectrum, diagnosis, treatment, and prevention of infections with E. coli O157:H7.
Similar articles
-
Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI. Ake JA, et al. Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236. Pediatrics. 2005. PMID: 15930195
-
Cohen MB. Cohen MB. Adv Pediatr. 1996;43:171-207. Adv Pediatr. 1996. PMID: 8794177 Review. No abstract available.
-
Shefer AM, Koo D, Werner SB, Mintz ED, Baron R, Wells JG, Barrett TJ, Ginsberg M, Bryant R, Abbott S, Griffin PM. Shefer AM, et al. West J Med. 1996 Jul-Aug;165(1-2):15-9. West J Med. 1996. PMID: 8855679 Free PMC article.
-
Hemolytic uremic syndrome: an emerging health risk.
Razzaq S. Razzaq S. Am Fam Physician. 2006 Sep 15;74(6):991-6. Am Fam Physician. 2006. PMID: 17002034 Review.
-
[Investigation of verotoxigenic Escherichia coli O157:H7 incidence in gastroenteritis patients].
Erdoğan H, Levent B, Erdoğan A, Güleşen R, Arslan H. Erdoğan H, et al. Mikrobiyol Bul. 2011 Jul;45(3):519-25. Mikrobiyol Bul. 2011. PMID: 21935785 Turkish.
Cited by
-
Bloch S, Lewandowska N, Zwolenkiewicz J, Mach P, Łukasiak A, Olejniczak M, Donaldson LW, Węgrzyn G, Nejman-Faleńczyk B. Bloch S, et al. PLoS One. 2023 Dec 20;18(12):e0296038. doi: 10.1371/journal.pone.0296038. eCollection 2023. PLoS One. 2023. PMID: 38117844 Free PMC article.
-
John M, Kudva IT, Griffin RW, Dodson AW, McManus B, Krastins B, Sarracino D, Progulske-Fox A, Hillman JD, Handfield M, Tarr PI, Calderwood SB. John M, et al. Infect Immun. 2005 May;73(5):2665-79. doi: 10.1128/IAI.73.5.2665-2679.2005. Infect Immun. 2005. PMID: 15845468 Free PMC article.
-
Naylor SW, Nart P, Sales J, Flockhart A, Gally DL, Low JC. Naylor SW, et al. Appl Environ Microbiol. 2007 Mar;73(5):1493-500. doi: 10.1128/AEM.01736-06. Epub 2007 Jan 12. Appl Environ Microbiol. 2007. PMID: 17220256 Free PMC article.
-
Dowling TC, Chavaillaz PA, Young DG, Melton-Celsa A, O'Brien A, Thuning-Roberson C, Edelman R, Tacket CO. Dowling TC, et al. Antimicrob Agents Chemother. 2005 May;49(5):1808-12. doi: 10.1128/AAC.49.5.1808-1812.2005. Antimicrob Agents Chemother. 2005. PMID: 15855500 Free PMC article. Clinical Trial.
-
Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.
Gamage SD, Strasser JE, Chalk CL, Weiss AA. Gamage SD, et al. Infect Immun. 2003 Jun;71(6):3107-15. doi: 10.1128/IAI.71.6.3107-3115.2003. Infect Immun. 2003. PMID: 12761088 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical